MedTrace Logo

Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia

NCT00415714 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2007-01-29

No results posted yet for this study

Summary

The objective of this study is to determine the efficacy of a portable biofeedback device on improving sleep latency and other sleep variables such as nocturnal awake time and daytime functioning in persons with primary insomnia.

Conditions

  • Primary Insomnia

Interventions

DEVICE

Portable Biofeedback

Sponsors & Collaborators

  • Helicor

    lead INDUSTRY

Principal Investigators

  • Jack Edinger, Ph.D. · Duke Unversity Medical Center

  • Charles Morin, Ph.D. · University of Laval

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00415714 on ClinicalTrials.gov